Skip to content

BBIOBRIDGEBIO PHARMA INC

CUSIP 10806X102 · common stock · Other share classes: 10806XAB8, 10806XAD4, 10806XAJ1

7 tracked investors held BRIDGEBIO PHARMA INC (BBIO) at the end of Q3 2026, worth $819.2M in total. The largest holder was Andreas Halvorsen, with 2.0% of its portfolio. Joel Greenblatt opened a new position this quarter.

Holders · Q3 2026
7
New holders
1
Value held
$819.2M
Quarter-end price (est.)
$65.80

Investors holding BBIO · Q3 2026

InvestorWeightSharesValueChange
Andreas Halvorsen
Viking Global Investors LP
1.97%9,792,219$644.3MREDUCE-1.6%
PRIMECAP Management
PRIMECAP Management Co
0.07%1,699,422$111.8MADD+67.3%
Adar1 Capital Management
ADAR1 Capital Management, LLC
1.06%379,261$25MADD+114.6%
Ken Fisher
Fisher Asset Management, LLC
0.01%348,675$22.9MADD+1.0%
Chuck Royce
Royce & Associates LP
0.13%218,487$14.4MHOLD
Joel Greenblatt
Gotham Asset Management, LLC
0.00%6,949$457.2KNEW
Polen Capital Management
Polen Capital Management LLC
0.00%4,510$296.8KADD+12.7%

History

QuarterHoldersNewSold outValue heldQuarter-end price (est.)
Q3 2026710$819.2M$65.80
Q2 2026600$872.1M$74.48
Q1 2026600$975.5M$74.26
Q4 2025600$1.2B$76.49